Karyopharm Therapeutics | 운영 비용

Operating Expenses 변화 날짜
AbbVie USD 11.11B 540M 2023-12
Amgen USD 6.93B 2.11B 2023-12
AstraZeneca USD 9.54B 578M 2023-09
Avrobio USD 22.93M 90.94M 2023-09
Eli Lilly USD 6.97B 2.08B 2023-12
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
Incyte USD 826.07M 121.75M 2023-12
Pfizer USD 20.8B 4.62B 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Takeda JPY 1.09T 202.38B 2023-09
TG Therapeutics USD 56.46M 5.42M 2023-12
Ultragenyx Pharmaceutical USD 249.44M 6.29M 2023-12
Xencor USD 79.7M 2.27M 2023-12



Karyopharm Therapeutics 운영 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Apr 2024.